Showing results (901-910 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2007
Early identification of drug-induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration-time profiles in ratSheila Annie Peters, Leif HultinJournal of Pharmacokinetics and Pharmacodynamics|November 9, 2007
Automated covariate selection and Bayesian model averaging in population PK/PD modelsDavid J LunnJournal of Pharmacokinetics and Pharmacodynamics|August 8, 2008
Likelihood based approaches to handling data below the quantification limit using NONMEM VIJae Eun Ahn, Mats O Karlsson, Adrian Dunne, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 8, 2008
Using spline-enhanced ordinary differential equations for PK/PD model developmentYi Wang, Kent Eskridge, Shunpu Zhang, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 21, 2007
Simulation of the reversal of neuromuscular block by sequestration of the free molecules of the muscle relaxantVladimir Nigrovic, Shashi B Bhatt, Anton AmannJournal of Pharmacokinetics and Pharmacodynamics|September 22, 2007
Mathematical modeling of topotecan pharmacokinetics and toxicodynamics in miceJin Chen, Qiang Lu, Joseph P BalthasarJournal of Pharmacokinetics and Pharmacodynamics|February 8, 2007
Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designsKayode Ogungbenro, Ivelina Gueorguieva, Oneeb Majid, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 31, 2015
Development of a paediatric population pharmacokinetic model for valacyclovir from literature non-compartmental values originating from sparse studies and Bayesian priors: a simulation studyIrene-Ariadne Kechagia, Aristides DokoumetzidisJournal of Pharmacokinetics and Pharmacodynamics|March 31, 2015
Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairmentLeonid Gibiansky, Mylène Giraudon, Craig R Rayner, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Multiple-pool cell lifespan model of hematologic effects of anticancer agentsWojciech Krzyzanski, William J JuskoPageof 107